Climb Bio, Inc. CLYM
11.66
(0.23)
(1.93%)
as of 25 Sep
- Market cap
- $682.9M
- P/E
- 0.0×
Follow CLYM
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(25.65%) | (32.15%) | (30.92%) | (27.10%) | |
| (25.09%) | (31.10%) | (29.90%) | (26.27%) | ||
ROIC |
(41.27%) | (71.43%) | (97.47%) | (71.73%) | |
Return on Tangible Assets |
(58.79%) | (60.36%) | (48.18%) | (31.77%) | |
Average Days of Receivables |
— | — | — | — | |
Free Cash Flow per Share |
(0.65) | (0.80) | (0.78) | (0.70) | |
Free Cash Flow |
(44.24) | (54.54) | (53.30) | (53.14) | |
Capital Expenditures |
— | (0.19) | — | (0.45) | |
Piotroski F-Score |
2.00 | 2.00 | 2.00 | 2.00 | |
| Other line items | |||||
Cash ROIC |
(16.76%) | (20.78%) | (20.69%) | (12.47%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.87 | 0.91 | 1.01 | 0.91 | |
Depreciation/Fixed assets |
(6.98) | (7.56) | (7.10) | (2.29) | |
Capex/Depreciation |
0.00 | 0.09 | 0.00 | 0.28 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.65) | (0.80) | (0.78) | (0.69) | |
Capex per Share |
0.00 | 0.00 | 0.00 | (0.01) | |
Capex to Sales |
— | 0.00 | — | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates